🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase I trial studies the best dose and side effects of NY-ESO-1 T cel...
Status
Terminated
Location
Roswell Park Cancer Institute
Start Date
2019-03-08
Trial ID
NCT03691376
Treatments Being Tested
This pilot, phase I trial studies the safety of cancer-testis antigen (NY-E...
Status
Completed
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2015-01
Trial ID
NCT02319824
This phase I trial studies how well autologous NY-ESO-1-specific CD8-positi...
Status
Completed
Location
M D Anderson Cancer Center
Start Date
2018-09-13
Trial ID
NCT03450122
A single center, dose escalaion, Phase I clinical trial to demonstrate safe...
Status
Recruiting
Location
Centre Hospitalier Universitaire Vaudois (CHUV)
Start Date
2025-03-24
Trial ID
NCT06889766
This phase I trial studies the side effects and best way to give NY-ESO-1 s...
Status
Withdrawn
Location
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Start Date
2014-07
Trial ID
NCT02059850